The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Pittsburgh.
Considering the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2013. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this UPMC works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from UPMC is 500 millions - 1 billion dollars.
The overall number of key employees were 3.
We can highlight the next thriving fund investment areas, such as Fitness, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Health Catalyst, medCPU, ALung Technologies The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the UPMC, startups are often financed by Norwest Venture Partners, Uncork Capital, Threshold. The meaningful sponsors for the fund in investment in the same round are Threshold, Froedtert Health, Philips Healthcare. In the next rounds fund is usually obtained by Threshold, Norwest Venture Partners, Froedtert Health.
Related Funds
Fund Name | Location |
AIB Equity | County Dublin, Dublin, Ireland |
Asgent | - |
Columbia Venture Competition | - |
curative ventures | Dallas, Texas, United States |
HBL Hadasit Bio Holdings | Israel, Jerusalem, Jerusalem District |
Internet Attitude | Belgium, Liege, Waremme |
Jiuli Jijin | China, Minhang, Shanghai |
Portico Ventures | - |
Qatar Science & Technology Park | Ad Dawhah, Doha, Qatar |
RNT Capital | - |
The Amherst Fund | Ann Arbor, Michigan, United States |
The Lind Partners | New York, New York, United States |
The Panther Opportunity Fund | Chicago, Illinois, United States |
Thornton Tomasetti | New York, New York, United States |
Traverse Venture Partners | District of Columbia, United States, Washington |
USAID East Africa Trade and Investment Hub | - |
Xinmei Touzi | - |
Yuanning Huizhi Investment Management | China, Hangzhou, Zhejiang |
Zhejiang Lusheng Shipen Keji Co., Ltd | China, Ningbo, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
Abridge | $10M | 06 Oct 2020 | Pittsburgh, Pennsylvania, United States | ||
Werewolf Therapeutics | $56M | 20 Nov 2019 | Cambridge, Massachusetts, United States | ||
Xealth | $11M | 27 Mar 2019 | Seattle, Washington, United States | ||
Globin Solutions | $5M | 11 May 2018 | Pittsburgh, Pennsylvania, United States | ||
Xealth | $8M | 13 Jun 2017 | Seattle, Washington, United States | ||
ALung Technologies | $36M | 11 Apr 2017 | Pittsburgh, Pennsylvania, United States | ||
Fabric Genomics (formerly Omicia) | $23M | 08 Jun 2016 | Oakland, California, United States | ||
Lantern | $17M | 10 Feb 2016 | San Francisco, California, United States |
– Xealth, the leader in enabling digital health at scale, announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health.
– Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care – join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health Network, MemorialCare Innovation Fund, Providence and UPMC.
– This brings the company’s total funding to date to $52.6 million.
– Use of digital therapeutics and remote patient monitoring is accelerating as they help fill a necessary role in extending care options for patients.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Xealth | $25M | 05 Oct 2021 | Seattle, Washington, United States | ||
Abridge | $10M | 06 Oct 2020 | Pittsburgh, Pennsylvania, United States | ||
Werewolf Therapeutics | $56M | 20 Nov 2019 | Cambridge, Massachusetts, United States | ||
Xealth | $11M | 27 Mar 2019 | Seattle, Washington, United States | ||
Globin Solutions | $5M | 11 May 2018 | Pittsburgh, Pennsylvania, United States | ||
Xealth | $8M | 13 Jun 2017 | Seattle, Washington, United States | ||
ALung Technologies | $36M | 11 Apr 2017 | Pittsburgh, Pennsylvania, United States | ||
Fabric Genomics (formerly Omicia) | $23M | 08 Jun 2016 | Oakland, California, United States | ||
Lantern | $17M | 10 Feb 2016 | San Francisco, California, United States |